Anna Kohn

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

William J. Sandborn, Subrata Ghosh, Julián Panés et al. · Clinical Gastroenterology and Hepatology · 2014 · 295 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +9

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Silvio Danese, Séverine Vermeire, Paul Hellstern et al. · Gut · 2017 · 174 citations · Full text

Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up

Anna Kohn, Marco Daperno, Alessandro Armuzzi et al. · Alimentary Pharmacology & Therapeutics · 2007 · 169 citations · Full text

Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.

Cosimo Prantera, Anna Kohn, R. Mangiarotti et al. · PubMed · 1994 · 115 citations

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

Matthieu Allez, Séverine Vermeire, Nicolas Mozziconacci et al. · Alimentary Pharmacology & Therapeutics · 2009 · 113 citations · Full text